28.06.2013 Views

Sclerotherapy for leg varicose veins - Institute of Health Economics

Sclerotherapy for leg varicose veins - Institute of Health Economics

Sclerotherapy for leg varicose veins - Institute of Health Economics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Coverage in Canada<br />

<strong>Sclerotherapy</strong> <strong>for</strong> <strong>leg</strong> <strong>varicose</strong> <strong>veins</strong><br />

In Alberta, the physician service <strong>for</strong> the injection(s) <strong>of</strong> sclerosing agents into<br />

symptomatic <strong>veins</strong> is an insured service when deemed medically necessary 61 . If<br />

per<strong>for</strong>med only <strong>for</strong> cosmetic reasons it is not covered by the Alberta <strong>Health</strong> Care<br />

Insurance Plan.<br />

Compression sclerotherapy (which includes multiple injections, compression bandaging<br />

and one post injection visit utilizing principles <strong>of</strong> Fegan) and repeat compression<br />

sclerotherapy are insured by the Ontario <strong>Health</strong> Insurance Schedule <strong>of</strong> Benefits <strong>for</strong><br />

Physician Services 62 . Physician assistant fees <strong>for</strong> these procedures are currently<br />

considered not medically necessary and are no longer insured in Ontario 62, 63 .<br />

“Simple sclerotherapy (removal <strong>of</strong> <strong>varicose</strong> <strong>veins</strong>)” is uninsured in Nova Scotia and has<br />

been de-insured in the province <strong>of</strong> Quebec and in Manitoba (Expert review, Documentreply<br />

#5).<br />

Coverage in the United States<br />

In the United States, insurance coverage varies and is considered both on the basis <strong>of</strong><br />

the agent and the technique 33, 64, 65 . In general, sclerotherapy is considered medically<br />

necessary and is covered when per<strong>for</strong>med <strong>for</strong> symptomatic <strong>varicose</strong> <strong>veins</strong> that have<br />

failed previous conservative treatment (such as compression therapy) <strong>of</strong> 1.5 to 6 months<br />

duration. Insurance plans do not cover treatment <strong>of</strong> telangiectasia or spider <strong>veins</strong> if the<br />

treatment is per<strong>for</strong>med solely <strong>for</strong> cosmetic reasons.<br />

Some insurance plans consider ultrasound or duplex-guided sclerotherapy techniques<br />

as investigational and reimbursement is not available when they are per<strong>for</strong>med solely<br />

to guide the needle or introduce the sclerosant into the <strong>varicose</strong> <strong>veins</strong> 32, 33, 34, 35, 65, 66 . A<br />

coverage policy by the United States <strong>Health</strong> Administration Center <strong>of</strong> the Department<br />

<strong>of</strong> Veterans Affair 67 approved USGS <strong>for</strong> use on the smaller and greater saphenous vein<br />

system when the medical record documents a justified need <strong>for</strong> ultrasound as an<br />

adjunct to sclerotherapy.<br />

AVAILABLE EVIDENCE ON EFFICACY/EFFECTIVENESS AND SAFETY<br />

The literature search revealed no randomized controlled trials (RCTs) that compared<br />

sclerotherapy (with or without ultrasound guidance) with conservative measures (such<br />

as compression therapy) or watchful waiting.<br />

Five RCTs 68-72 conducted to evaluate the safety and efficacy/effectiveness <strong>of</strong><br />

sclerotherapy <strong>for</strong> <strong>leg</strong> <strong>varicose</strong> <strong>veins</strong> were considered <strong>for</strong> this review. Two systematic<br />

reviews 1, 13 recently produced on the effects <strong>of</strong> treatments in patients with <strong>varicose</strong><br />

<strong>veins</strong> were also included in this review. Details <strong>of</strong> reviewed RCTs and an assessment <strong>of</strong><br />

these studies’ methodological quality are provided in Table 3 and Table 4, Appendix C.<br />

Alberta Heritage Foundation <strong>for</strong> Medical Research<br />

<strong>Health</strong> Technology Assessment<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!